PublizoomAward notice Supplies
Adjudicación del Contrato Específico del Medicamento TAFAMIDIS 61 MG CÀPSULA, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, para la Corporació de Salut del Maresme i la Selva
Notice published in Spanish. The AI analysis summarises it for you in your language.
- Public buyer
- Corporació de Salut del Maresme i la Selva
Calella - Place of performance
- Calella
- Estimated value
- €389,574 excl. VAT
- Amount awarded
- €389,574 excl. VAT
- Planned end of contract
- 17 July 2027
likely re-tender around January 2027 - Bids received
- 1
- Procedure
- Restricted procedure
You first submit an application; only shortlisted candidates are invited to bid. - Publication
- 23 October 2026
- Notice language
- Spanish
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Adjudicación del Contrato Específico del Medicamento TAFAMIDIS 61 MG CÀPSULA, para la Corporació de Salut del Maresme i la Selva derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, tramitado por el Consorci de Salut i d’Atenció Social de Catalunya
Awarded to
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33690000
Winning prices for comparable contracts
- A quarter below
- €202,502
- Median
- €425,325
- A quarter above
- €1,046,198
Amounts awarded (excl. VAT) over the last 3 years for 163 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 735784-2026.